Riggs Asset Management’s bluebird bio BLUE Stock Holding History

Riggs Asset Management’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-350	Closed	-$1.71K	–	923
2025 Q1	$1.71K	Hold	350	–	–	﹤0.01%	415
2024 Q4	$2.75K	Hold	350	–	–	﹤0.01%	349
2024 Q3	$3.64K	Hold	350	–	–	﹤0.01%	314
2024 Q2	$6.89K	Hold	350	–	–	﹤0.01%	281
2024 Q1	$8.96K	Buy	+350	New	+$8.97K	﹤0.01%	249
2021 Q2	–	Sell	-19	Closed	-$8K	–	313
2021 Q1	$8K	Buy	+19	New	+$9.36K	﹤0.01%	221

Other funds holding BLUE

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Riggs Asset Management's BLUE Position: Q2 2025 in Review

Riggs Asset Management sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 350 shares — an estimated $1.71K sold.

Riggs Asset Management first reported a position in BLUE in Q1 2021 and held it in 6 quarters. The position peaked at $8.96K in Q1 2024. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.

Riggs Asset Management reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
Riggs Asset Management sold 350 bluebird bio shares in Q2 2025, an estimated $1.71K.
Riggs Asset Management first reported a position in bluebird bio in Q1 2021 and held it in 6 quarters.
Riggs Asset Management's bluebird bio position peaked at $8.96K in Q1 2024.
3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.

Based on Riggs Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.